Published in Antimicrob Agents Chemother on January 01, 1977
Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria. Antimicrob Agents Chemother (1981) 2.71
Susceptibility of anaerobic bacteria to ten antimicrobial agents. Antimicrob Agents Chemother (1978) 2.45
Effect of clavulanic Acid on anaerobic bacteria resistant to Beta-lactam antibiotics. Antimicrob Agents Chemother (1978) 1.78
Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance. Antimicrob Agents Chemother (1990) 1.75
Purification and properties of beta-lactamase from Bacteroides fragilis. Antimicrob Agents Chemother (1978) 1.71
New medium for selection and presumptive identification of the Bacteroides fragilis group. J Clin Microbiol (1978) 1.55
Purification and properties of a novel beta-lactamase from Fusobacterium nucleatum. Antimicrob Agents Chemother (1985) 1.15
Penicillin resistance in the subgingival microbiota associated with adult periodontitis. J Clin Microbiol (1986) 1.13
Characterization of a beta-lactamase found in Eikenella corrodens. Antimicrob Agents Chemother (1991) 0.97
Isoelectric focusing of Bacteroides melaninogenicus group beta-lactamases. Antimicrob Agents Chemother (1981) 0.93
Antibiotic susceptibility of black-pigmented Bacteroides isolates from the human oral cavity. Antimicrob Agents Chemother (1982) 0.91
Mechanisms of resistance to cephalosporin antibiotics. Drugs (1987) 0.82
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother (1972) 61.10
In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother (1972) 11.05
Modified broth-disk method for testing the antibiotic susceptibility of anaerobic bacteria. Antimicrob Agents Chemother (1973) 9.35
Microiodometric determination of beta-lactamase activity. Antimicrob Agents Chemother (1972) 4.28
Cephalosporinase activity in Bacteroides fragilis. Antimicrob Agents Chemother (1973) 3.27
Bacteroides penicillinase. J Bacteriol (1968) 3.10
Beta-lactamase activity in anaerobic bacteria. Antimicrob Agents Chemother (1976) 2.75
Influence of pencillinase production by strains of Bacteroides melaninogenicus and Bacteriodes oralis on pencillin therapy of an experimental mixed anaerobic infection in mice. Arch Oral Biol (1976) 1.39
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology (2010) 12.32
Medium for use in antibiotic susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1976) 9.38
Modified broth-disk method for testing the antibiotic susceptibility of anaerobic bacteria. Antimicrob Agents Chemother (1973) 9.35
Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl Environ Microbiol (1977) 8.29
Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science (1999) 7.66
NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell (1998) 7.58
Clostridium difficile: its disease and toxins. Clin Microbiol Rev (1988) 7.26
Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun (1982) 6.88
Early treatment of acute biliary pancreatitis by endoscopic papillotomy. N Engl J Med (1993) 5.84
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science (2001) 5.25
Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J (2000) 5.22
Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria. Antimicrob Agents Chemother (1979) 5.10
Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg (1999) 4.97
A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell (1999) 4.65
Biological activities of toxins A and B of Clostridium difficile. Infect Immun (1982) 4.62
Development of a micromethod for identification of anaerobic bacteria. Appl Microbiol (1975) 4.58
Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44
Regions in Bacteroides plasmids pBFTM10 and pB8-51 that allow Escherichia coli-Bacteroides shuttle vectors to be mobilized by IncP plasmids and by a conjugative Bacteroides tetracycline resistance element. J Bacteriol (1986) 4.38
Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med (1992) 4.29
Fermentation of mucins and plant polysaccharides by anaerobic bacteria from the human colon. Appl Environ Microbiol (1977) 4.09
Identification and characterization of variable-number tandem repeats in the Yersinia pestis genome. J Clin Microbiol (2001) 4.08
Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun (1990) 4.06
Insertion and excision of Bacteroides conjugative chromosomal elements. J Bacteriol (1992) 4.02
Production of Clostridium difficile antitoxin. Infect Immun (1980) 3.95
Tn4351 transposes in Bacteroides spp. and mediates the integration of plasmid R751 into the Bacteroides chromosome. J Bacteriol (1986) 3.90
Micromethod for identification of anaerobic bacteria: design and operation of apparatus. Appl Microbiol (1975) 3.80
Mobilization of Bacteroides plasmids by Bacteroides conjugal elements. J Bacteriol (1988) 3.77
Evidence for extensive resistance gene transfer among Bacteroides spp. and among Bacteroides and other genera in the human colon. Appl Environ Microbiol (2001) 3.56
Cellular location of enzymes involved in chondroitin sulfate breakdown by Bacteroides thetaiotaomicron. J Bacteriol (1980) 3.54
Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clin Microbiol Rev (1992) 3.51
Evidence that the clindamycin-erythromycin resistance gene of Bacteroides plasmid pBF4 is on a transposable element. J Bacteriol (1985) 3.45
Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg (1998) 3.43
Enzyme-linked immunosorbent assay for Clostridium difficile toxin A. J Clin Microbiol (1983) 3.40
Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg (2001) 3.25
Cloning and characterization of a Bacteroides conjugal tetracycline-erythromycin resistance element by using a shuttle cosmid vector. J Bacteriol (1989) 3.25
Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer (2000) 3.23
A prospective study on fish bone ingestion. Experience of 358 patients. Ann Surg (1990) 3.19
Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg (1999) 3.05
Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg (1995) 3.04
Francisella tularensis strain typing using multiple-locus, variable-number tandem repeat analysis. J Clin Microbiol (2001) 2.99
Biochemical evidence that starch breakdown by Bacteroides thetaiotaomicron involves outer membrane starch-binding sites and periplasmic starch-degrading enzymes. J Bacteriol (1989) 2.95
Genetic evidence that outer membrane binding of starch is required for starch utilization by Bacteroides thetaiotaomicron. J Bacteriol (1989) 2.94
Nucleotide sequence of Clostridium difficile toxin B gene. Nucleic Acids Res (1990) 2.93
A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci U S A (1991) 2.93
Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc. Infect Immun (1986) 2.89
A Bacteroides thetaiotaomicron outer membrane protein that is essential for utilization of maltooligosaccharides and starch. J Bacteriol (1996) 2.87
Investigation of an outbreak of antibiotic-associated colitis by various typing methods. J Clin Microbiol (1982) 2.86
Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg (1997) 2.83
Use of a species-specific DNA hybridization probe for enumerating Bacteroides vulgatus in human feces. Appl Environ Microbiol (1985) 2.79
Bacteroides of the human lower intestinal tract. Annu Rev Microbiol (1984) 2.78
Characterization of four outer membrane proteins that play a role in utilization of starch by Bacteroides thetaiotaomicron. J Bacteriol (1997) 2.72
Isolation and characterization of outer membranes of Bacteroides thetaiotaomicron grown on different carbohydrates. J Bacteriol (1984) 2.67
Arginine, a growth-limiting factor for Eubacterium lentum. J Bacteriol (1976) 2.67
Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect Immun (1982) 2.65
Production by Salmonella typhimurium of 2,3-dihydroxybenzoylserine, and its stimulation of growth in human serum. J Infect Dis (1970) 2.62
Characterization of four outer membrane proteins involved in binding starch to the cell surface of Bacteroides thetaiotaomicron. J Bacteriol (2000) 2.57
Tetracycline-dependent appearance of plasmidlike forms in Bacteroides uniformis 0061 mediated by conjugal Bacteroides tetracycline resistance elements. J Bacteriol (1988) 2.56
Genetic locus in mice that blocks development of atherosclerosis despite extreme hyperlipidemia. Circ Res (2001) 2.55
Compliance with postoperative instructions: a telephone survey of 750 day surgery patients. Anaesthesia (2001) 2.53
Mismatch repair co-opted by hypermutation. Science (1998) 2.49
Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect Immun (1992) 2.49
A cryptic 65-kilobase-pair transposonlike element isolated from Bacteroides uniformis has homology with Bacteroides conjugal tetracycline resistance elements. J Bacteriol (1990) 2.48
Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol (1999) 2.47
Medium-dependent inhibition of Peptostreptococcus anaerobius by sodium polyanetholsulfonate in blood culture media. J Clin Microbiol (1976) 2.46
Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A. J Clin Microbiol (1985) 2.46
Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44
Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg (1995) 2.37
alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol (2000) 2.36
Location and characteristics of the transfer region of a Bacteroides conjugative transposon and regulation of transfer genes. J Bacteriol (1995) 2.34
Use of an Escherichia coli beta-glucuronidase gene as a reporter gene for investigation of Bacteroides promoters. J Bacteriol (1991) 2.30
Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg (1994) 2.22
A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation. J Immunol (1981) 2.20
HDAC3: taking the SMRT-N-CoRrect road to repression. Oncogene (2007) 2.19
Breakdown of mucin and plant polysaccharides in the human colon. Can J Biochem (1977) 2.19
Effects of the intermittent Pringle manoeuvre on hepatic gene expression and ultrastructure in a randomized clinical study. Br J Surg (2003) 2.19
Location and characterization of genes involved in binding of starch to the surface of Bacteroides thetaiotaomicron. J Bacteriol (1992) 2.18
Use of randomly cloned DNA fragments for identification of Bacteroides thetaiotaomicron. J Bacteriol (1983) 2.17
Contribution of a neopullulanase, a pullulanase, and an alpha-glucosidase to growth of Bacteroides thetaiotaomicron on starch. J Bacteriol (1996) 2.15
Effect of regulatory protein levels on utilization of starch by Bacteroides thetaiotaomicron. J Bacteriol (1996) 2.15
Genes involved in production of plasmidlike forms by a Bacteroides conjugal chromosomal element share amino acid homology with two-component regulatory systems. J Bacteriol (1992) 2.15
Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol (2001) 2.15
Production of antitoxins to two toxins of Clostridium difficile and immunological comparison of the toxins by cross-neutralization studies. Infect Immun (1982) 2.14
Antiretroviral resistance during successful therapy of HIV type 1 infection. Proc Natl Acad Sci U S A (2000) 2.13
A Bacteroides tetracycline resistance gene represents a new class of ribosome protection tetracycline resistance. Antimicrob Agents Chemother (1992) 2.11
Recent advances in Bacteroides genetics. Crit Rev Microbiol (1987) 2.09
Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg (1997) 2.09
Induction of chondroitin sulfate lyase activity in Bacteroides thetaiotaomicron. J Bacteriol (1980) 2.08
Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study. Aliment Pharmacol Ther (2014) 2.06
The enterotoxin of Bacteroides fragilis is a metalloprotease. Infect Immun (1995) 2.06
Familial colorectal cancer risk by subsite of primary cancer: a population-based study in Utah. Aliment Pharmacol Ther (2015) 2.03
Distribution and molecular analysis of Lyme disease spirochetes, Borrelia burgdorferi, isolated from ticks throughout California. J Clin Microbiol (1993) 2.03
Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg (2000) 2.01
Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies. Infect Immun (1986) 2.01
Cilia with defective radial spokes: a cause of human respiratory disease. N Engl J Med (1979) 2.01
Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro. Infect Immun (1988) 2.00
A prospective study of operative risk factors in perforated duodenal ulcers. Ann Surg (1982) 2.00